Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank89
3Y CAGR+18.1%
5Y CAGR+8.7%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+18.1%/yr
vs +12.9%/yr prior
5Y CAGR
+8.7%/yr
Recent acceleration
Acceleration
+5.2pp
Accelerating
Percentile
P89
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $49.30M | -4.3% |
| 2024 | $51.52M | +51.9% |
| 2023 | $33.92M | +13.4% |
| 2022 | $29.91M | -7.9% |
| 2021 | $32.48M | -0.0% |
| 2020 | $32.49M | +21.9% |
| 2019 | $26.64M | +44.7% |
| 2018 | $18.41M | +123.5% |
| 2017 | $8.24M | -4.5% |
| 2016 | $8.62M | - |